- |||||||||| NN1213 / Novo Nordisk
Enrollment change: Deployment Related Mild Traumatic Brain Injury (mTBI) (clinicaltrials.gov) - Feb 25, 2019 P=N/A, N=750, Completed, Recruiting --> Completed | Trial completion date: Dec 2017 --> Mar 2017 | Trial primary completion date: Dec 2017 --> Jan 2017 N=1500 --> 750
- |||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: The Effect of tDCS on Subcortical Brain Functioning (clinicaltrials.gov) - Dec 21, 2018
P=N/A, N=3, Terminated, Active, not recruiting --> Completed N=150 --> 3 | Trial completion date: Dec 2020 --> Oct 2018 | Enrolling by invitation --> Terminated | Trial primary completion date: Sep 2020 --> Oct 2018; Difficulty identifying appropriate patients
- |||||||||| dexamethasone / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: DECS: Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma (clinicaltrials.gov) - Dec 11, 2018 P2/3, N=10, Terminated, N=150 --> 3 | Trial completion date: Dec 2020 --> Oct 2018 | Enrolling by invitation --> Terminated | Trial primary completion date: Sep 2020 --> Oct 2018; Difficulty identifying appropriate patients N=300 --> 10 | Recruiting --> Terminated | Trial primary completion date: Mar 2017 --> Dec 2017; Accrual too slow; Study P.I. passed away.
- |||||||||| NN1213 / Novo Nordisk
Enrollment closed, Trial completion date, Trial primary completion date: EpoRepair: Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (clinicaltrials.gov) - Nov 23, 2018 P3, N=120, Active, not recruiting, Recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: Dec 2021 --> Mar 2024 | Trial primary completion date: Feb 2021 --> Dec 2023
- |||||||||| NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial termination: Written Versus Verbal Education for Mild Traumatic Brain Injury (clinicaltrials.gov) - Nov 15, 2018 P=N/A, N=12, Terminated, Phase classification: P=N/A --> P2 N=80 --> 12 | Trial completion date: Dec 2015 --> Apr 2016 | Recruiting --> Terminated; Low enrollment
- |||||||||| Trial termination: AC105 in Patients With Acute Traumatic Spinal Cord Injury (clinicaltrials.gov) - Nov 6, 2018
P2, N=15, Terminated, N=80 --> 12 | Trial completion date: Dec 2015 --> Apr 2016 | Recruiting --> Terminated; Low enrollment Completed --> Terminated; The study was terminated by the Sponsor due to insufficient enrollment.
- |||||||||| NN1213 / Novo Nordisk
Enrollment change, Trial withdrawal: Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury (clinicaltrials.gov) - Oct 25, 2018 P1, N=0, Withdrawn, Completed --> Terminated; The study was terminated by the Sponsor due to insufficient enrollment. N=166 --> 0 | Completed --> Withdrawn
- |||||||||| NN1213 / Novo Nordisk
Enrollment change, Trial withdrawal: Stem Cell Therapy in Traumatic Brain Injury (clinicaltrials.gov) - Oct 25, 2018 P1, N=0, Withdrawn, N=166 --> 0 | Completed --> Withdrawn N=43 --> 0 | Completed --> Withdrawn
- |||||||||| NN1213 / Novo Nordisk
Enrollment change, Trial withdrawal: Stem Cell Therapy in Spinal Cord Injury (clinicaltrials.gov) - Oct 25, 2018 P2, N=0, Withdrawn, N=43 --> 0 | Completed --> Withdrawn N=500 --> 0 | Recruiting --> Withdrawn
- |||||||||| NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI (clinicaltrials.gov) - Oct 4, 2018 P2, N=11, Terminated, N=30 --> 11 | Trial completion date: Jun 2017 --> Aug 2018 | Not yet recruiting --> Terminated | Trial primary completion date: Jun 2015 --> Aug 2018; Recruitment was slower than anticipated. Incomplete neuropsychological outcome measures obtained.
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Normative Datasets for Assessments Planned for Mild Traumatic Brain Injury (NORMAL) (clinicaltrials.gov) - Aug 27, 2018 P=N/A, N=83, Completed, Recruiting --> Completed | N=20000 --> 26873 Active, not recruiting --> Completed | Trial completion date: Feb 2017 --> Jan 2016 | Trial primary completion date: Feb 2017 --> Jan 2016
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Use of a Traumatic Brain Injury (TBI) Screen in a Veteran Mental Health Population (clinicaltrials.gov) - Aug 14, 2018
P=N/A, N=1810, Completed, Not yet recruiting --> Completed | N=20 --> 8 | Trial completion date: Dec 2015 --> Feb 2017 | Trial primary completion date: Aug 2015 --> Jan 2017 Active, not recruiting --> Completed | N=3000 --> 1810 | Trial completion date: Dec 2016 --> Aug 2016 | Trial primary completion date: Dec 2016 --> Aug 2016
- |||||||||| NN1213 / Novo Nordisk
Enrollment closed, Enrollment change, Trial completion date: MUBI: Efficacy and Neural Basis of Music-based Neurological Rehabilitation for Traumatic Brain Injury (clinicaltrials.gov) - Aug 13, 2018 P=N/A, N=40, Active, not recruiting, Active, not recruiting --> Completed | N=3000 --> 1810 | Trial completion date: Dec 2016 --> Aug 2016 | Trial primary completion date: Dec 2016 --> Aug 2016 Recruiting --> Active, not recruiting | N=60 --> 40 | Trial completion date: Dec 2017 --> Dec 2018
- |||||||||| NN1213 / Novo Nordisk
Enrollment closed, Trial completion date, Trial primary completion date: Comparison of Two Psycho-educational Family Group Interventions for Persons With SCI and Their Caregivers (clinicaltrials.gov) - Aug 2, 2018 P=N/A, N=64, Active, not recruiting, Recruiting --> Completed | N=90 --> 8 | Trial completion date: Dec 2017 --> Mar 2017 | Trial primary completion date: Dec 2017 --> Mar 2017 Recruiting --> Active, not recruiting | Trial completion date: Mar 2018 --> Jun 2019 | Trial primary completion date: Mar 2018 --> Dec 2018
- |||||||||| NN1213 / Novo Nordisk
Trial completion: Power Over Pain (POP) Study (clinicaltrials.gov) - Jun 27, 2018 P=N/A, N=177, Completed, Recruiting --> Active, not recruiting | Trial completion date: Mar 2018 --> Jun 2019 | Trial primary completion date: Mar 2018 --> Dec 2018 Active, not recruiting --> Completed
|